OCULAR HYPEREMIA
Clinical trials for OCULAR HYPEREMIA explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPEREMIA trials appear
Sign up with your email to follow new studies for OCULAR HYPEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops promise quick redness relief in minutes
Symptom relief Not yet recruitingThis study tests an investigational eye drop (FID 123472) to see how well and how safely it reduces eye redness from minor irritations in adults. About 178 participants will receive either the active drop or a placebo (vehicle). The main goal is to measure redness reduction 15 mi…
Matched conditions: OCULAR HYPEREMIA
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
New eye drops aim to soothe red eyes fast
Symptom relief Not yet recruitingThis Phase 3 trial tests an investigational eye drop (FID123472) containing apraclonidine to reduce redness in adults with minor eye irritation. About 230 participants will receive either the active drop or a placebo (vehicle). The main goals are to see if redness improves within…
Matched conditions: OCULAR HYPEREMIA
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC